ImmunoCellular Therapeutics Ltd
OTC:IMUC
Shareholder Yield
Current shareholder yield for 
IMUC is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
IMUC Price
ImmunoCellular Therapeutics Ltd
| Average Annual Return | -23.79% |
| Standard Deviation of Annual Returns | 34.08% |
| Max Drawdown | -95% |
| Market Capitalization | 40.8m USD |
| Shares Outstanding | 254 717 612 |
| Percentage of Shares Shorted | 3.96% |
IMUC Return Decomposition
Main factors of price return
Stock Splits
IMUC's latest stock split occurred on Sep 16, 2020
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, IMUC traded at 0.03 per share. Afterward, the share price was about 0.5.
The adjusted shares began trading on Sep 16, 2020. This was IMUC's 2nd stock split, following the previous one in Nov 21, 2016.
